Navigation Links
Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics
Date:8/17/2011

NEW YORK, Aug. 17, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics

http://www.reportlinker.com/p0590267/Needle-Free-Drug-Delivery-The-Market-for-Alternatives-to-Needle-Based-Systems-for-Vaccine-and-Biologics.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

The line between drug delivery and drug substance will continue to become more elusive in the near future as shown in the analysis, as researchers work to improve drug properties through drug design and molecular modeling. Consequently, in the next decade, drug delivery technologies will be a focal point of competition within the pharmaceutical industry.

This Kalorama Information report, Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics takes a look at this aspect of the pharmaceutical marketplace with figures and forecasts for pharmaceutical companies and the companies that supply technology to them. The success of specific drugs will be tied to innovative delivery techniques, which will enable the targeting that will exploit the clinical properties of a new generation of drugs.

The needle-free drug delivery market is growing rapidly. The development of better delivery systems in conjunction with the discovery of novel pharmacological compounds will lead to significant improvements in drug delivery. This report looks at that trend and reports current and forecasted revenues for the injectable drug delivery market, segmented into two main categories:

  • Needle-Free Products Market (Including Drug and Technology)

  • Needle-Free Products Market (Technology Only)

This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. The report also includes information that will be of assistance to business planners:

  • Trends in the Vaccine Market

  • Market Size and Forecast for Needle-Free Vaccine Technology

  • Trends in Biopharmaceuticals

  • Leading Pharmaceutical Product Sold With Needle-Free Technologies

  • Products in Development

  • Detailed Profiles of Key Companies in Needle-Free Technologies.

  • Current Market Size and Forecasts to 2013

  • Needle-Free Cost Savings, Autojets, Health Care Reform, and Other Trends and Developments

CHAPTER ONE: EXECUTIVE SUMMARY

Market Drivers

Demographics

Pediatrics

Market Size and Growth

Total Needle-free Drug Delivery Market

The Needle-free Drug Delivery Only Market

Competitor and Market Analysis

Biotech Markets

CHAPTER TWO: INTRODUCTION

Scope and Methodology

Drug Delivery Systems

Phases of Drug Action

Pharamcokinetics

Needle-Free Drug Delivery

Auto-injectors

Pen Injectors

Major Applications

Self-Administration

Vaccine Delivery

Safety Concerns

Local Reactions

Needle-Free Products

Review of Major Products on the Market

Biojector 2000

Vitajet

Injex Drug Delivery System

PowderMed

Intraject

Glide

MediJector

MiniJect

Crossject

PenJet

Fentanyl ITS

PLEASE

CHAPTER THREE: TRENDS AND DEVELOPMENTS

Pen Injectors

Auto-injectors

Pen-Prep

King

KwikPen

ImplanJect

Bioject ID

Novel Vaccine Delivery Development

Edible Vaccines

Mucosal Delivery

Intranasal Delivery

Vaccine Patches

Vaccine Chips

Delivery Systems Placement Trends

Nanotechnology

Drug Delivery Development

MicroChip Technology

DNA Vaccines

Needle-Free Delivery Development

Medical House/Dr. Reddy's

Flugen

Inviragen

Other

Selected Products in Development

CHAPTER FOUR MARKET SIZE AND GROWTH

Competitive Landscape

Market Size and Forecast

Cost Considerations

Drivers of the Needle-free Drug Delivery Market

Biologics

Cancer

Market

Forecast

Growth Expectation

Drug Delivery Development

MicroChip Technology

DNA Vaccines

Needle-Free Delivery Development

Medical House/Dr. Reddy's

Flugen

Inviragen

Other

Selected Products in Development

Drug Delivery Technology Only Market

Needle Free Vaccine Delivery Market

Childhood Immunization in the United States

Childhood Immunization Rates

Challenges to the Vaccine Delivery System

US Healthcare Reform

Market for Pediatric Vaccines

Market for Needle-Free Vaccine Delivery Systems

CHAPTER FIVE CONCLUSIONS

Conclusion 1

Conclusion 2

Conclusion 3

Conclusion 4

Conclusion 5

CHAPTER SiX COMPANY PROFILES

ALZA Corp.

DUROS

ALZAMER

Antares Pharma, Inc.

Medi-Jector VISION

Medi-Jector MJ8

Vibex

Aridis Pharmaceuticals, Inc

Becton Dickinson and Company

Accuspray

Revenues

Bioject Medical Technologies, Inc.

Jupiter Jet

Glide Pharma

ImplaJect

Intercell AG

MedImmune, Inc

Mystic Pharmaceuticals, Inc

Optinose, Inc

Pharmajet, Inc

PowderMed, Inc/Pfizer

PowderMed

Ypsomed Holding AG

ServoPen

Zogenix Corporation

Zosano Pharma

APPENDIX: COMPANY DIRECTORY

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Figure 1-1: Worldwide Market for Needle-Free Delivery

CHAPTER TWO: INTRODUCTION

Table 2-1: Sequence of Drug Action

CHAPTER THREE: TRENDS AND DEVELOPMENTS

Table 3-1: Select Products in Development by Drug Delivery Companies

CHAPTER FOUR: MARKET SIZE AND GROWTH

Table 4-1: Needle-Free Drug Delivery Technology Participants

Figure 4-1: Cost per Million Injections by Injector Type

Table 4-2: Worldwide Market for Needle-Free Drug Delivery Technology and Pharmaceuticals 2009-2016

Figure 4-2: Needle-Free Drug Delivery Technology and Pharmaceuticals 2009-2016

Figure 4-3: The Worldwide Market for Needle-Free Delivery Systems, Technology Only Revenues, 2009 to 2016

Table 4-3: The Worldwide Market for Needle-Free Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2009-2016

Figure 4-4: The Worldwide Market for Needle-Free Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2011

Table 4-4: Global Immunization Rates by Vaccine Type 2008

Table 4-5: Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 2002-2008

Figure 4-6: Pediatric Vaccine Market, 2005-2014

Figure 4-7: Needle Free Vaccine Delivery Systems Market, 2009-2016

To order this report:

Drug Delivery Technology Industry: Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics

Drug Delivery Technology Business News

More  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tevas Needle-Free Tjet(R) Device Takes a Kid-Friendly Approach to Growth Hormone Deficiency Treatment
2. SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System
3. Echo Therapeutics Initiates Needle-Free Biosensor Program for Continuous Lactate Monitoring
4. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
5. St. Renatus, LLC, with Guidance from the U.S. Food and Drug Administration, Has Established Readiness to Proceed to Phase 3 Trials for a New Needle-Free Dental Anesthetic
6. Reportlinker Adds Injectable Drug Delivery: Market Impact and Industry Trends
7. Reportlinker Adds U.S. Inflammatory Diseases Drug Delivery: Physician Perspective
8. Reportlinker Adds RNAi Drug Delivery: Technologies and Global Markets
9. Microneedle Drug Delivery: Technology, Devices, Markets, Players and Prospects
10. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
11. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... 2016 Research and Markets has announced ... in the USA"  report to their offering.  ,     (Logo: ... the current Positron Emission Tomography (PET) scanner and cyclotron ... market. Along with the current known number of PET ... , the report also contains a detailed breakdown of ...
(Date:5/5/2016)... 5, 2016 ... of the  "Europe Thrombocytopenia Market and ... to their offering.       ... ,The latest research Europe Thrombocytopenia Market ... provides comprehensive insights into Thrombocytopenia pipeline ...
(Date:5/4/2016)... Conn., May 4, 2016  Compass Diversified Holdings (NYSE: ... "Company"), an owner of leading middle market businesses, announced ... ended March 31, 2016. First Quarter 2016 ... and Reinvestment ("CAD" or "Cash Flow") of $13.6 million ... net loss of $15.0 million for the first quarter ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... 06, 2016 , ... From May 4 to 6, EarQ and ... opportunity to learn more about Signia’s technology and the successful business and marketing techniques ... priority to see practices succeed in this highly competitive industry,” said Ed Keller, president ...
(Date:5/6/2016)... Arizona (PRWEB) , ... May 06, 2016 , ... ... moved domains to Sleepopolis.com . , Since launching in September, 2014 Sleepopolis ... research and testing areas, which now include pillows, sheets, mattress toppers, bed frames, ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... online provider of career-focused education and corporate training, and the National Military Family ... to announce Maritza Aquino as the second full-tuition scholarship recipient of 2016. ...
(Date:5/6/2016)... ... May 06, 2016 , ... RowdMap, Inc. ... Cross BlueShield and Former Principal Deputy Administrator at Centers for Medicare and Medicaid ... Steve Ondra, MD, Chief Medical Officer at Health Care Service Corporation (Blue Cross ...
(Date:5/5/2016)... ... May 05, 2016 , ... Qrono Inc. , ... a development collaboration with the Australian critical medicine company, Phebra Pty Ltd. ... , LAI medicines can offer improved therapeutic benefits over oral formulations, including better ...
Breaking Medicine News(10 mins):